During 2018 Q3 the big money sentiment decreased to 1.24. That’s change of 2.51, from 2018Q2’s 3.75. 17 investors sold all, 25 reduced holdings as SIEN ratio dived. 32 increased holdings while 20 funds acquired holdings. Funds hold 24.04 million shares thus 50.28% less from 2018Q2’s 48.35 million shares. Deutsche Bancorporation Ag stated it has 46,452 shs. Emerald Advisers Inc Pa, a Pennsylvania-based fund reported 27,000 shs. The Minnesota-based Next Century Growth Investors Ltd Liability Corporation has invested 0.52% in Sientra, Inc. (NASDAQ:SIEN). Moreover, Wells Fargo And Communication Mn has 0% invested in Sientra, Inc. (NASDAQ:SIEN) for 68,133 shs. Federated Investors Pa has 0% invested in Sientra, Inc. (NASDAQ:SIEN). Ameritas Partners Inc holds 0% in Sientra, Inc. (NASDAQ:SIEN) or 2,102 shs. Vanguard Gru owns 1.02 million shs or 0% of their US capital. Moreover, Tower Capital Ltd Liability Company (Trc) has 0% invested in Sientra, Inc. (NASDAQ:SIEN) for 113 shs. Thompson Davis & Incorporated stated it has 0.17% in Sientra, Inc. (NASDAQ:SIEN). Royal Comml Bank Of Canada reported 0% in Sientra, Inc. (NASDAQ:SIEN). Aqr Cap Lc owns 13,670 shs. Northern Trust stated it has 302,544 shs or 0% of all its holdings. The California-based California Employees Retirement Systems has invested 0% in Sientra, Inc. (NASDAQ:SIEN). 2.20M were accumulated by Abingworth Llp. Atika Capital Management Ltd owns 1.1% invested in Sientra, Inc. (NASDAQ:SIEN) for 256,600 shs.

SIEN registered $1.98 million net activity with 0 insider purchases and 2 sales since August 31, 2018. Another trade for 1,852 shs valued at $46,115 was sold by Nugent Jeffrey M.

In 2018Q3 Securities and Exchange filling is reported Abingworth Llp’s holdings in Sientra (SIEN) which was reduced by 11.35%. 281,482 shares were sold by Abingworth Llp as the company’s stock declined 33.70% with the market. At the end of 2018Q3, the institutional investor held 2.20M shares of the health care company, valued at $52.51 million, down from 2.48 million at the end of the previous reported quarter. For a total of shares it increased its holding in by shares in the quarter, and has risen its stake in .

Sientra, Inc. (NASDAQ:SIEN)’s earnings release is awaited by WallStreet on March, 12, RTT reports. Analysts forecast 26.09 % diference or $-0.68 from the $-0.92 EPS from 2018. Last quarter $-0.72 EPS was reported. Analysts forecasts -5.56 % EPS growth this quarter.

For more Sientra, Inc. (NASDAQ:SIEN) news released recently go to: Globenewswire.com, Nasdaq.com, Globenewswire.com, Globenewswire.com or Globenewswire.com. The titles are as follows: “Sientra Receives FDA Approval of PMA Supplement – GlobeNewswire” released on April 18, 2018, “Notable Tuesday Option Activity: AMTD, SIEN, PRLB – Nasdaq” on January 22, 2019, “Sientra® to Release Third Quarter 2018 Financial Results on November 6, 2018 – GlobeNewswire” with a publish date: October 23, 2018, “Sientra® to Release Second Quarter 2018 Financial Results on August 7, 2018 – GlobeNewswire” and the last “Sientra Reports Third Quarter 2018 Financial Results Nasdaq:SIEN – GlobeNewswire” with publication date: November 06, 2018.